Clinical and immunological efficiency of different therapy regimens in patients with infectious mononucleosis caused by Epstein-Barr virus

Abstract

The study of the role of Epstein-Barr virus (EBV) infection in the occurrence of various pathological human conditions is of great importance. This is due to the significant epidemiological role and social significance, as according to epidemiological data more than 90 % of people are already infected with EBV when they reach adulthood. The steady increase in the number of diseases caused by EBV in both adults and children, due to its specific tropism to immunocompetent cells, lifelong persistence, and latent course, necessitates a comprehensive study and development of effective treatment methods. Therefore, it is very important to conduct research to find effective treatment regimens that aim to rehabilitate the immune system, promote the regression of immune changes and complications and prevent recurrence in various forms of EBV infection.